Delivery Order SPE2DB20D1051-SPE2DB24FD6ZK

Award Date 2/9/24
Potential Completion Date 2/12/24
Potential Value $4.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, through its Corporate Office division, was awarded a $5,157.69 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide TOPAMAX 50 MG TABLET 60S. This delivery order contract has a completion date of March 8, 2024 and was awarded on March 7, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is a prime contractor that provides a wide range of pharmaceutical products and medical supplies to U.S....
The U.S. Defense Logistics Agency (DLA) awarded a $12,893.60 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TOPAMAX 50 MG TABLET 60S, a pharmaceutical product. This delivery order contract has an ultimate completion date of March 18, 2024 and was awarded on March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a Firm Fixed Price Delivery Order contract by the Defense Logistics Agency (DLA) to provide TOPAMAX 50 MG TABLET 60S. The total potential value of the contract is $8,629.35 with a completion date of February 22, 2024. This contract is not associated with any set-aside designation. Amerisourcebergen Drug Corp serves as the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA, with a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $1,040.53 for the supply of TOPAMAX 100 MG TABLET 60S, a pharmaceutical product. The contract has a completion date of February 10, 2025 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is the prime contractor, and the contract does not have a set-aside...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The order is for the supply of TOPAMAX 25 MG TABLET 60S, with a potential value of $4,983.51 and a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is not associated with any overarching contract vehicles. No set-aside...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is to provide TOPAMAX 200 MG TABLET 60S, a pharmaceutical product, with a potential value of $6,962.51 and a completion date of January 2, 2024. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is a prime contractor that has received multiple federal...
The U.S. Defense Logistics Agency (DLA) awarded a $21,372.07 Firm Fixed Price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of TOPAMAX 50 MG TABLET 60S. This contract, which has an ultimate completion date of May 2, 2024, is not designated as a set-aside. Amerisourcebergen, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, provides a wide range of prescription medications, over-the-counter drugs, and medical supplies...
This firm fixed price delivery order, valued at $3,008.52, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the delivery of TOPAMAX 200 MG TABLET 60S, a pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TOPAMAX 50 MG TABLET 60S. The contract has a ceiling value of $1,029.00 and is a Firm Fixed Price delivery order with a completion date of September 13, 2024. The contract is not set aside for any specific business type. AmerisourceBergen, through its Corporate Office division, will provide the required pharmaceutical product to support...
This is a $10,183.41 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The delivery order is for the provision of TOPAMAX 50 MG TABLET 60S, a pharmaceutical product. This award is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that serves as the primary vehicle for Amerisourcebergen...
  • SPE2DB20D1051
    Indefinite Delivery Contract
  • SPE2DB20D1051-SPE2DB24FD6ZK
    Delivery Order

Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide TOPAMAX 200 MG TABLET 60S, a pharmaceutical product. The $4,075.26 contract has a completion date of February 12, 2024 and does not utilize any set-aside designations. This delivery order is issued under Amerisourcebergen Drug Corp's indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December 31, 2025, to deliver a comprehensive range of medications and medical supplies to military treatment programs and facilities worldwide.

Generated 5/10/24, 10:58 AM